… Extracorporeal photopheresis (ECP) was initially developed for use in cutaneous T-cell …
Here, also, long-term treatment (years) seems to lead to continuous improvement of this …

… In conclusion, progressive improvement in cutaneous and extracutaneous cGVHD was
observed after a 24-week course of ECP in patients who previously had no clinical improvement …

… patients with steroid-refractory cGVHD, progressive improvement in the TSS during weeks 16
… Significantly improved survival rates and improvements in quality of life in ECP responders …

… important that outcome measures record best clinical improvement but also disease
stabilization, prevention from further disability or death from chronic progressive AID are important. …

Extracorporeal photopheresis (ECP) has had a major impact in the treatment of various
conditions in the past 25 years. Although it was initially developed for the treatment of patients …

… In this study, 14 patients improved with seven attaining remission by 12 weeks. Of five
patients who had persistently open fistulas, three patients experienced fistula closure after ECP …

… studies with varying outcome, ranging from no improvement against no treatment, improvement
over no treatment but no improvement against sham to a superiority of ECP against D-…

… Extracorporeal photochemotherapy (ECP) was introduced in … clinical response and faster
improvement in patients receiving … treatment leads to continuous improvement in SSc patients. …

… Extracorporeal photopheresis (ECP) is a therapy that combines the collection of … GvHD, the
steroid-sparing effect, and the improved overall survival of treated patients, made ECP one of …

… Other dedicated continuous or … improved functionality, reduced symptoms and improved
well-being. Despite not reaching a partial response (better by 50%) in skin diseases, continuous …